PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 20260 citations

Role of echo-enhancer in CDI-ophthalmology preliminary assessment in a wide-ranged pathology serie

PSPapa SergioCMCaputo MauroSMSbrocca Michele

Key Points

  • All retrobulbar vessels were detectable after intravenous administration of echo-enhancer, improving visibility.
  • Peak velocity, mean average, and resistive index measures remained unaffected by the echo-enhancer during assessments.
  • Assessment of the blood flow was achieved without interference from the echo-enhancer, maintaining data accuracy.
  • Highlights the potential of echo-enhancer in evaluating ocular pathologies, especially in cases like neoplasias and occlusions.

Abstract

Aim of this study is a preliminary assessment of CDI-ophthalmological samplings, by using echo-enhancer, in a wide range of various pathologies. Our serie was made out by 15 patients affected by a range of ocular vascular disturbancies, such as hypertensive and low-tensive glaucoma, myopia, choroideal tumors and acute occlusive syndromes of central retinal vessels. All examined before and after intravenous administration of echo-enhancer, with Peak Velocity, Mean Average, and RI survey. We pointed, after the `blooming' phase, good detection of all retrobulbar vessels, even those previous undetectable. Furthermore, spectral data never showed themselves to be affected by enhancer, being quite completely similar than without. Finally, we never observed blood flow signals, in treated choroideal tumors. Echo-enhancer allowed us to achieve efficient samplings in all cases; unaffected velocity data; good prognostic evaluation in treated neoplasias; good recanalization assessment in acute occlusions.

Ask AI
Helpful
Bookmark
Share

Cite This Study

Sergio et al. (1997) studied this question.

synapsesocial.com/papers/69a75fbcc6e9836116a2b821
Ask AI
Helpful
Bookmark
Share